Eledon Pharmaceuticals Inc. (ELDN) jumped 16% to $43.31 and a $198 million market cap. The Irvine-based clinical trial company said today it will highlight topline results from its Phase 2 BESTOW ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback